Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
153 Leser
Artikel bewerten:
(0)

General Anaesthesia Drugs Market 2015 - 2025 - Expected to Register a CAGR of 3.8% - Research and Markets

DUBLIN, April 8, 2016 /PRNewswire/ --

Research and Marketshas announced the addition of the"General Anaesthesia Drugs Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

This industry offers a 10-year forecast of the global general anaesthesia drugs market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 3.8% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the general anaesthesia drugs market over the forecast period.

Increasing incidences of cardiovascular and chronic diseases, coupled with rising demand for surgical procedures is predicted to increase usages of general anaesthesia drugs worldwide. This is expected to bolster growth of the general anaesthesia drugs market over the next five to six years. Increasing demand for inhalation general anaesthesia drugs, for maintaining the sedative stage during surgical procedures, especially among the children and elderly population is expected to drive growth of general anaesthesia drugs market during the forecast period.

Companies are focused on populations driving the market such as: Asia Pacific and MEA, where incidences of cardiovascular and chronic disease are increasing, this is expected to further increase the demand of general anaesthesia drugs during surgical procedures.

Key Segments Covered:

  • Product Type
  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others

Key Topics Covered:

1. Assumptions & Acronyms Used

2. Research Methodology

3. Executive Summary

4. Global General Anaesthesia Drugs Market

5. Global General Anaesthesia Drugs Market Overview

6. Global General Anaesthesia Drugs Market Outlook, By Product

7. Global General Anaesthesia Drugs Market Outlook, By Region

8. Global General Anaesthesia Drugs Market, By Region

9. Competitive Landscape

  • Baxter International Inc.
  • AstraZeneca
  • AbbVie Inc.
  • B. Braun Melsungen AG s
  • Fresenius SE & Co. KGaA
  • Hospira Inc.

For more information visithttp://www.researchandmarkets.com/research/wfgvq6/general


Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com


For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900


U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.